Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenoma of large intestine
|
213 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Adrenoleukodystrophy
|
116 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Adult Liver Carcinoma
|
72 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Alcoholic Liver Diseases
|
20 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
Cardiovascular Diseases
|
711 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||
Chronic liver disease
|
14 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||
Chronic viral hepatitis
|
8 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Cirrhosis
|
110 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Diabetes
|
710 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Diabetes Mellitus
|
824 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.720 | 1.000 | 3 | 2018 | 2018 | ||||
Dyslipidemias
|
184 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Fatty Liver
|
35 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.100 | 1.000 | 11 | 2015 | 2018 | ||||
Fatty Liver Disease
|
81 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.050 | 1.000 | 5 | 2015 | 2017 | ||||
Fibrosis, Liver
|
64 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2014 | 2016 | ||||
HCV coinfection
|
5 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Hepatitis B
|
519 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||
Hepatitis B, Chronic
|
84 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Hepatitis C
|
347 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.040 | 1.000 | 4 | 2016 | 2019 | ||||
Hepatitis C, Chronic
|
80 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.040 | 0.750 | 4 | 2015 | 2017 | ||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Hypertriglyceridemia
|
169 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Insulin resistance syndrome
|
15 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Liver carcinoma
|
942 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.070 | 1.000 | 7 | 2016 | 2019 |